Precision BioSciences Inc (DTIL)
9.67
-1.06
(-9.88%)
USD |
NASDAQ |
Apr 19, 16:00
9.67
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Max Drawdown (5Y): 98.55% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 98.55% |
February 29, 2024 | 98.55% |
January 31, 2024 | 98.55% |
December 31, 2023 | 98.55% |
November 30, 2023 | 98.55% |
October 31, 2023 | 98.55% |
September 30, 2023 | 98.26% |
August 31, 2023 | 97.71% |
July 31, 2023 | 97.36% |
June 30, 2023 | 97.36% |
May 31, 2023 | 96.44% |
April 30, 2023 | 96.44% |
March 31, 2023 | 96.44% |
February 28, 2023 | 95.07% |
January 31, 2023 | 95.07% |
December 31, 2022 | 95.07% |
November 30, 2022 | 94.15% |
October 31, 2022 | 94.15% |
September 30, 2022 | 94.15% |
August 31, 2022 | 94.15% |
July 31, 2022 | 94.15% |
June 30, 2022 | 94.15% |
May 31, 2022 | 92.27% |
April 30, 2022 | 89.88% |
March 31, 2022 | 84.94% |
Date | Value |
---|---|
February 28, 2022 | 79.50% |
January 31, 2022 | 78.38% |
December 31, 2021 | 76.35% |
November 30, 2021 | 76.35% |
October 31, 2021 | 76.35% |
September 30, 2021 | 76.35% |
August 31, 2021 | 76.35% |
July 31, 2021 | 76.35% |
June 30, 2021 | 76.35% |
May 31, 2021 | 76.35% |
April 30, 2021 | 76.35% |
March 31, 2021 | 76.35% |
February 28, 2021 | 76.35% |
January 31, 2021 | 76.35% |
December 31, 2020 | 76.35% |
November 30, 2020 | 76.35% |
October 31, 2020 | 76.35% |
September 30, 2020 | 76.35% |
August 31, 2020 | 76.30% |
July 31, 2020 | 76.30% |
June 30, 2020 | 76.30% |
May 31, 2020 | 76.30% |
April 30, 2020 | 76.30% |
March 31, 2020 | 74.31% |
February 29, 2020 | 64.79% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
32.14%
Minimum
Apr 2019
98.55%
Maximum
Oct 2023
79.85%
Average
76.35%
Median
Sep 2020
Max Drawdown (5Y) Benchmarks
Altimmune Inc | 99.85% |
BioVie Inc | 98.82% |
Adial Pharmaceuticals Inc | 99.30% |
Gritstone Bio Inc | 96.17% |
Humacyte Inc | -- |